Category: Rare Blood Cancers

Highlights from attending the 2023 ASH Annual Meeting

Lee Greenberger, PhD, The Leukemia & Lymphoma Society, Rye Brook, NY

What’s New in the Treatment of BPDCN?

Naveen Pemmaraju, MD, The University of Texas MD Anderson Cancer Center, Houston, TX

Mastocytosis: Insight into a Rare Blood Cancer

Jason Gotlib, MD, Stanford University School of Medicine, Palo Alto, CA

BPDCN – Expert Insight Into a Rare Blood Cancer

Naveen Pemmaraju, MD, MD Anderson Cancer Center, Houston, TX
Scroll to Top